Catheter Precision raises $4.9M gross via warrant repricing; issues new Series K warrants

Catheter Precision, Inc.

Total gross proceeds of $4.9M, including $3.7M from warrant repricing and $1.185M from prior exercises.
Exercise price reduced from $1.00/$30/$40 to $0.70 per share for Series E, F, G, H, I warrants.
New Series K warrants issued for 200% of exercised shares, $0.70 exercise price, 5.5-year term, exercisable only after shareholder approval.
Pro forma shares outstanding approximately 10.8 million after warrant exercises.
Ladenburg Thalmann served as exclusive warrant inducement agent with an 8% cash fee.

item 1.01 item 3.02 item 3.03 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.